EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Flagellin as a Versatile Adjuvant Platform: Genetic Fusion Approaches for Next-Generation Vaccines

Eugenia S Mardanova iD, Nikolai V Ravin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eugenia S Mardanova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia. Hauptthemen laut MEDLINE: Flagellin, Adjuvants, Immunologic, Vaccines, Adjuvants, Vaccine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flagellin is the main structural protein of the bacterial flagellum, responsible for the movement of flagellated bacteria. Flagellin activates Toll-like receptor 5, inducing both innate and adaptive immune reactions, which highlights its potential as a vaccine adjuvant, particularly efficient in case of administration via mucosal routes. Genetic fusion of an antigen to flagellin has been shown to enhance the immune responses against the antigen. The molecular architecture of flagellin provides versatile and robust adjuvant functionality, facilitating the development of diverse vaccination strategies against multiple diseases as recombinant protein-based vaccines demonstrate substantial advantages over conventional live-attenuated and inactivated vaccines in both developmental efficiency and safety profiles. We present a comprehensive overview of vaccine design strategies employing genetic fusion of antigens to flagellin for protection against various infectious diseases. The proven effectiveness of flagellin-based delivery has enabled several vaccine candidates to enter clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlagellinAdjuvants, ImmunologicVaccinesAdjuvants, VaccineHumansAnimalsToll-Like Receptor 5Vaccine Development

Stichwörter der Autor:innen

adjuvantantigenflagellintoll-like receptor 5vaccine

Substanzen

FlagellinAdjuvants, ImmunologicVaccinesAdjuvants, VaccineToll-Like Receptor 5

Autor:innen und Institutionen

  • Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.

ORCID-Profile: Eugenia S Mardanova, Nikolai V Ravin

Förderung

  • Russian Science Foundation

Zitieren

APA

Mardanova, E. S., & Ravin, N. V. (2025). Flagellin as a Versatile Adjuvant Platform: Genetic Fusion Approaches for Next-Generation Vaccines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110295

Vancouver

Mardanova ES, Ravin NV. Flagellin as a Versatile Adjuvant Platform: Genetic Fusion Approaches for Next-Generation Vaccines. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110295

BibTeX
@article{Mardanova2025,
  author = {Mardanova, Eugenia S and Ravin, Nikolai V},
  title = {Flagellin as a Versatile Adjuvant Platform: Genetic Fusion Approaches for Next-Generation Vaccines},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110295}
}
Kostenlos starten →